Announcements Trials
Browse Landscape

Phase

Phase 2 6

Status

Completed 6

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Conditions

Warts 6Urinary Bladder Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Melanoma 1Esophageal Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

resiquimod 6VP-102 2N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Cantharidin 22-Propanol 2methyl 5-aminolevulinate 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1Sugars 1Photochemotherapy 1Nitric Oxide 1Maltose 1Interferon-alpha 1Imiquimod 1Exercise 1Equipment and Supplies 1Cryotherapy 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Warts × resiquimod × Clear all
NCT00114920 2007-02-19

Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Graceway Pharmaceuticals, LLC

Phase 2 Completed
88 enrolled

Warts

NCT00115141 2007-02-19

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Graceway Pharmaceuticals, LLC

Phase 2 Completed
88 enrolled

Warts

NCT00116662 2007-02-19

An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Graceway Pharmaceuticals, LLC

Phase 2 Completed
84 enrolled

Warts

NCT00116675 2007-02-19

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Graceway Pharmaceuticals, LLC

Phase 2 Completed
84 enrolled

Warts

NCT00117871 2007-02-19

Study With a Topical Gel to Treat Common Warts in Adults

Graceway Pharmaceuticals, LLC

Phase 2 Completed
48 enrolled

Warts

NCT00117923 2007-02-19

Study With a Topical Gel to Treat Common Warts in Adults

Graceway Pharmaceuticals, LLC

Phase 2 Completed
88 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡